(lp0
S'Lexicon Pharmaceuticals Inc.  Plunges 5.8% on March 21 Equities.com - Mar 21, 2017 Lexicon Pharmaceuticals Inc.  had a rough trading day for Tuesday March 21 as shares tumbled 5.8%, or a loss of $-0.86 per share, to close at $13.98.'
p1
aS'Earnings Reaction History: Lexicon Pharmaceuticals Inc., 33.3% Follow-Through ... Nasdaq - Mar 3, 2017 Lexicon Pharmaceuticals Inc.  is due to issue its quarterly earnings report in the upcoming extended-hours session.'
p2
aS"FDA OKs Lexicon Pharma's telotristat etiprate for carcinoid syndrome Seeking Alpha - Feb 28, 2017 The FDA approves Lexicon Pharmaceuticals'  XERMELO  250 mg for the treatment of carcinoid syndrome diarrhea, in combination with somatostatin therapy  in adult patients inadequately controlled with SSA therapy.Lexicon Pharma  Announces FDA Approval for XERMELO to Treat Carcinoid ... - StreetInsider.com"
p3
aS'Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 ... PR Newswire  - Mar 3, 2017 THE WOODLANDS, Texas, March 3, 2017 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. , today reported financial results for the three months and year ended December 31, 2016 and provided an overview of key milestones for the&nbsp;...Lexicon Pharmaceuticals Inc.  Moves Lower on Volume Spike for March 02 - Equities.comLexicon Pharmaceuticals, Inc.  Issues Quarterly Earnings Results, Beats ... - Chaffey Breeze'
p4
aS'Lexicon Pharmaceuticals Inc.  Moves Higher on Volume Spike for February 27 Equities.com - Feb 27, 2017 Lexicon Pharmaceuticals Inc.  traded on unusually high volume on Feb. 27, as the stock gained 4.64% to close at $16.45.Lexicon Pharmaceuticals  Stock: FDA Approves XERMELO - CNA Finance The Lexicon Pharmaceuticals, Inc.  Upgraded by Zacks Investment Research ... - DailyQuint'
p5
aS"What are Analyst's Indicators for Cathay General Bancorp , Lexicon ... The USA Commerce - 18 hours ago While trading at volume above than average, Lexicon Pharmaceuticals, Inc.  previous 52-week high was $19.62 and moved up 16.21% over the same period, trading at a volume of 1.07 million.Today's Brokerage Rating: Cathay General Bancorp , Lexicon ... - StockNewsJournal"
p6
aS'Lexicon To Present At The Cowen And Company 37th Annual Healthcare Conference PR Newswire  - Mar 6, 2017 THE WOODLANDS, Texas, March 6, 2017 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc.  announced today that Lexicon management will present at the Cowen and Company 37th Annual Healthcare Conference on Wednesday, March 8,&nbsp;...'
p7
aS'Estimating the intrinsic value of Lexicon Pharmaceuticals Inc  Simply Wall St - Mar 3, 2017 How far off is Lexicon Pharmaceuticals  to its intrinsic value? I am going to take a look now using a method called discounted cash flow or DCF.'
p8
aS'Buckling Under the Trendline, Can This Stock Reverse Course: Lexicon ... Midway Monitor - 8 hours ago Shares of Lexicon Pharmaceuticals, Inc.  have been on a recent steady downtrend, causing some worry for shareholders.30 hedge funds buy Lexicon Pharmaceuticals, Inc.  for the first time - Post AnalystStock Performance Review: Lexicon Pharmaceuticals, Inc.  - The Oracle Examiner'
p9
aS'Analyst Sentiment Outlines Long Term Upside for Lexicon Pharmaceuticals, Inc ... Aiken Advocate - 5 hours ago Shaers of Lexicon Pharmaceuticals, Inc.  have been recommended as a long term growth pick according to Beta Research.'
p10
a.